TACI antibody (N-Term)
Quick Overview for TACI antibody (N-Term) (ABIN121880)
Target
See all TACI (TNFRSF13B) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- This antibody is specific for the CD267 cell surface antigen, also known as transmembrane activator and CAML interactor (TACI).
-
Purification
- Affinity chromatography
-
Immunogen
- Synthetic peptide corresponding to a region within the N-terminus of human CD267
-
-
-
-
Application Notes
-
Western Blot: 2 μg/mL - 5 μg/mL, this antibody detects a band of approximately 32 kD in K562 cell lysates.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
-
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
Shelf Life: one year from despatch. -
Expiry Date
- 12 months
-
-
- TACI (TNFRSF13B) (Tumor Necrosis Factor Receptor Superfamily, Member 13B (TNFRSF13B))
-
Alternative Name
- CD267 / TACI
-
Background
- CD267 is a member of the tumour necrosis factor family, which is expressed by B lymphocytes, activated T lymphocytes and myeloma cells. CD267 is a a receptor for BAFF and CD256 (APRIL), and is thought to play an important regulatory role in B-cell homeostasis and autoimmunity.Synonyms: TNFRSF13B, Transmembrane activator and CAML interactor, Tumor necrosis factor receptor superfamily member 13B
-
Gene ID
- 23495
-
UniProt
- O14836
Target
-